Literature DB >> 23462050

Plasmacytoid dendritic cells: key players in viral infections and autoimmune diseases.

Karina Santana-de Anda1, Diana Gómez-Martín, Rodrigo Soto-Solís, Jorge Alcocer-Varela.   

Abstract

OBJECTIVE: Describe the main activation and inhibitory pathways and receptors by which pDC regulate type I interferon secretion, as well as its association with autoimmune pathology.
METHODS: A PubMed search for articles was conducted using the following key words: plasmacytoid dendritic cells, autoimmune diseases, viral infections and type I interferon. The search was limited to publications in English and from 1957 to 2012. Sixty-five of these articles are included in this review. The most relevant primary research articles identified were critically evaluated and compiled together. Particularly, areas of consensus and controversy were identified and analyzed.
RESULTS: Plasmacytoid dendritic cells have been closely related to viral infections and autoimmune disease, mainly because of these immune cells are able to secrete large amounts of type I interferon. This function is linked with their expression of Toll-like receptors, specially TLR7 and TLR9, which are designed to sense nucleic acids in the early endosomes. Activated pDC can promote immunity and autoimmunity, however, the exact mechanisms by which pDC promote one vs. the other are not well understood.
CONCLUSIONS: Plasmacytoid dendritic cells play a key role in both, immunity and autoimmunity. Current evidence suggests that the sustained overproduction of type-I interferon drives aberrant immune responses and the development of autoimmune pathology.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmune diseases; Dendritic cells; Interferon regulatory factor; Toll-like receptors; Type I interferon

Mesh:

Year:  2013        PMID: 23462050     DOI: 10.1016/j.semarthrit.2012.12.026

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  8 in total

Review 1.  HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication.

Authors:  Jonathan Herskovitz; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2018-03-23       Impact factor: 4.147

Review 2.  Pathogenesis and treatment of autoimmune rheumatic diseases.

Authors:  Eric Liu; Andras Perl
Journal:  Curr Opin Rheumatol       Date:  2019-05       Impact factor: 5.006

3.  Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps.

Authors:  Flávio V Loures; Marc Röhm; Chrono K Lee; Evelyn Santos; Jennifer P Wang; Charles A Specht; Vera L G Calich; Constantin F Urban; Stuart M Levitz
Journal:  PLoS Pathog       Date:  2015-02-06       Impact factor: 6.823

4.  Association of social and cognitive impairment and biomarkers in autism spectrum disorders.

Authors:  Altaf Alabdali; Laila Al-Ayadhi; Afaf El-Ansary
Journal:  J Neuroinflammation       Date:  2014-01-08       Impact factor: 8.322

5.  Tolerogenic Plasmacytoid Dendritic Cells Control Paracoccidioides brasiliensis Infection by Inducting Regulatory T Cells in an IDO-Dependent Manner.

Authors:  Eliseu Frank de Araújo; Daniella Helena Medeiros; Nayane Alves de Lima Galdino; Antônio Condino-Neto; Vera Lúcia Garcia Calich; Flávio Vieira Loures
Journal:  PLoS Pathog       Date:  2016-12-19       Impact factor: 6.823

Review 6.  Disease-Associated Plasmacytoid Dendritic Cells.

Authors:  Shuang Li; Jing Wu; Shan Zhu; Yong-Jun Liu; Jingtao Chen
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

Review 7.  CD8+ T Lymphocytes: Crucial Players in Sjögren's Syndrome.

Authors:  Huimin Zhou; Jun Yang; Jie Tian; Shengjun Wang
Journal:  Front Immunol       Date:  2021-01-28       Impact factor: 7.561

Review 8.  Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren's Syndrome.

Authors:  Hideki Nakamura; Yoshiro Horai; Toshimasa Shimizu; Atsushi Kawakami
Journal:  Int J Mol Sci       Date:  2018-08-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.